Latest Articles

Publication Date
Common symptom was terminal cancer - The Chronicle | The Chronicle

Common symptom was terminal cancer The Chronicle | The Chronicle

Published: June 18, 2026, 12:30 p.m.
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia - Vera Health

Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia Vera Health

Published: June 18, 2026, 12:22 p.m.
Early Prime Day air fryer deals: Shop Instant Pot, Ninja, and more - Mashable

Early Prime Day air fryer deals: Shop Instant Pot, Ninja, and more Mashable

Published: June 18, 2026, 11:44 a.m.
‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis - Adelaide Now

‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis Adelaide Now

Published: June 18, 2026, 9:41 a.m.
‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis - Gold Coast Bulletin

‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis Gold Coast Bulletin

Published: June 18, 2026, 9:39 a.m.
‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis - The Cairns Post

‘I won’t see them grow up’: Mum’s fatigue reveals devastating diagnosis The Cairns Post

Published: June 18, 2026, 9:37 a.m.
Toi Et Moi The Handmaid's Tale (agdSTSk3vb) - fernandovasconcelos.com

Toi Et Moi The Handmaid's Tale (agdSTSk3vb) fernandovasconcelos.com

Published: June 18, 2026, 9:36 a.m.
Early Prime Day beauty deals: Save on my favorite products from Solawave, Drybar, and more - Mashable

Early Prime Day beauty deals: Save on my favorite products from Solawave, Drybar, and more Mashable

Published: June 18, 2026, 8:55 a.m.
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR

Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR

Published: June 18, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Macau Business

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Macau Business

Published: June 18, 2026, 7:26 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!